OR7E62P

Across TCGA pan-cancer cohorts, OR7E62P RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated OR7E62P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher OR7E62P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E62P expression acts as an unfavorable survival marker, although some lineages such as THCA and HNSC show a favorable association.

UCEC, UVM, and THCA are the cancer types where OR7E62P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.465	0.781	<.001	98	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	54	view →
THCA	OS	Tertile	III,IV	1.000	0.942	.008	50	view →
BRCA	OS	Quartile	All	0.524	0.668	.001	46	view →
HNSC	DFS	Median	All	0.679	0.564	.013	44	view →
TGCT	DFS	Tertile	II,III,IV	0.657	1.000	.007	36	view →
ACC	DFS	Tertile	IV	0.010	0.383	<.001	36	view →
READ	DFS	Quartile	IV	0.307	0.746	.007	24	view →
PAAD	DFS	Tertile	All	0.192	0.394	.004	19	view →
KIRC	DFS	Tertile	All	0.735	0.834	.012	17	view →
COAD	DFS	Median	All	0.374	0.562	.011	17	view →
DLBC	DFS	Tertile	III,IV	0.196	0.827	.017	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

OR7E62P–UCEC (DFS)

Open the UCEC breakdown →